why choose us

First received: November 10, 2023

Clinical Trial: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Focal Epilepsy

Study Type: INTERVENTIONAL


Official Title: A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy

Brief Summary: The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Read more